NEW MACROLIDE ANTIBIOTICS - CLARITHROMYCIN AND AZITHROMYCIN

被引：0
|
作者：
STOTT, GA
机构：
来源：
AMERICAN FAMILY PHYSICIAN | 1992年 / 46卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Clarithromycin and azithromycin are new semisynthetic macrolide antibiotics structurally related to erythromycin. They are well absorbed and widely distributed, with excellent cellular and tissue penetration. Both have a broader spectrum of activity and fewer gastrointestinal side effects than erythromycin. Currently, clarithromycin and azithromycin are approved by the U.S. Food and Drug Administration for respiratory tract infections and skin infections, but they may also have use in mycobacterial and Toxoplasma infections in patients with acquired immunodeficiency syndrome.
引用
收藏
页码：863 / 869
页数：7
相关论文
共 50 条
  • [31] Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers
    M. Eisenblätter
    C. Klaus
    M. W. R. Pletz
    H. Orawa
    H. Hahn
    J. Wagner
    H. Lode
    European Journal of Clinical Microbiology & Infectious Diseases, 2008, 27 : 1087 - 1092
  • [32] Reversed-phase liquid chromatographic behavior of the macrolide antibiotics clarithromycin and roxithromycin
    A. Pappa-Louisi
    P. Agrafiotou
    Chromatographia, 2002, 55 : 541 - 547
  • [33] Reversed-phase liquid chromatographic behavior of the macrolide antibiotics clarithromycin and roxithromycin
    Pappa-Louisi, A
    Agrafiotou, P
    CHROMATOGRAPHIA, 2002, 55 (9-10) : 541 - 547
  • [34] Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers
    Eisenblaetter, M.
    Klaus, C.
    Pletz, M. W. R.
    Orawa, H.
    Hahn, H.
    Wagner, J.
    Lode, H.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2008, 27 (11) : 1087 - 1092
  • [35] RELATIVE POTENCIES OF AZITHROMYCIN, CLARITHROMYCIN AND 5 OTHER ORALLY-ADMINISTERED ANTIBIOTICS
    BARRY, AL
    FUCHS, PC
    BROWN, SD
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (04) : 552 - 555
  • [36] COMPARATIVE INVITRO ACTIVITY OF THE NEW ORAL MACROLIDE AZITHROMYCIN
    NEU, HC
    CHIN, NX
    SAHA, G
    LABTHAVIKUL, P
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (04) : 541 - 544
  • [37] THE NEW MACROLIDE ANTIBIOTICS AND TERFENADINE - COMMENT
    CORTESE, LM
    BJORNSON, DC
    ANNALS OF PHARMACOTHERAPY, 1992, 26 (7-8) : 1019 - 1019
  • [38] A platform for the discovery of new macrolide antibiotics
    Seiple, Ian B.
    Zhang, Ziyang
    Jakubec, Pavol
    Langlois-Mercier, Audrey
    Wright, Peter M.
    Hog, Daniel T.
    Yabu, Kazuo
    Allu, Senkara Rao
    Fukuzaki, Takehiro
    Carlsen, Peter N.
    Kitamura, Yoshiaki
    Zhou, Xiang
    Condakes, Matthew L.
    Szczypinski, Filip T.
    Green, William D.
    Myers, Andrew G.
    NATURE, 2016, 533 (7603) : 338 - +
  • [39] Comparative Study of the Effect of Macrolide Antibiotics Erythromycin, Clarithromycin, and Azithromycin on the ERG1 Gene Expression in H9c2 Cardiomyoblast Cells
    Hajimirzael, Nima
    Khalili, Nazila Pour
    Boroumand, Behshad
    Safari, Fatemeh
    Pourhosseini, Armin
    Judi-Chelan, Reza
    Tavakoli, Fatemeh
    DRUG RESEARCH, 2020, 70 (08) : 341 - 347
  • [40] NEW DRUGS INTERACTIONS WITH MACROLIDE ANTIBIOTICS
    CARRY, PV
    DUCLUZEAU, R
    JOURDAN, C
    BOURRAT, C
    VIGNEAU, C
    DESCOTES, J
    LYON MEDICAL, 1982, 248 (16): : 189 - 190
12345